Effectiveness of Extracorporeal Vacuum Suction System in Upper Gastrointestinal Endoscopy

Quantitative Study on Prevention of Aerosol Diffusion by Extracorporeal Vacuum Suction System in Upper Gastrointestinal Endoscopy during Coronavirus disease (COVID-19) pandemic. - Prevention of Aerosol Diffusion by extracorporeal vacuum suction System in Upper Gastrointestinal Endoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046779

Enrollment

Registered

2022-02-01

Start date

2022-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing upper gastrointestinal endoscopy for health check or screening

Exclusion criteria

Exclusion criteria: 1. Patients who need emergency endoscopic treatment such as gastrointestinal bleeding 2. Patients with psychiatric diseases or psychiatric symptoms who are judged to have difficulty in conducting this clinical trial 3. Patients who the doctor in charge deems inappropriate

Design outcomes

Primary

Measure	Time frame
Comparison of six particle sizes (0.3/0.5/1.0/3.0/5.0/10micrometre) before and after endoscopy using an extracorporeal vacuum suction device during upper gastrointestinal endoscopy using a particle counter.	—

Secondary

Measure	Time frame
The surface ATP of the examiner's personal protective equipment (gown surface, goggles, etc.) is compared before and after endoscopy using an ATP lumitester while using an extracorporeal vacuum suction device.	—

Countries

Japan

Contacts

Public ContactHideki Kobara

Kagawa University, Faculty of Medicine Department of Gastroenterology and Neurology

kobara.hideki@kagawa-u.ac.jp0878912156

Outcome results